Join to View Full Profile
250 25th Ave NSte 100Nashville, TN 37203
Phone+1 615-320-5090
Dr. Burris is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
San Antonio Uniformed Services Health Education ConsortiumFellowship, Hematology and Medical Oncology, 1988 - 1991- San Antonio Uniformed Services Health Education ConsortiumResidency, Internal Medicine, 1985 - 1988
University of South Alabama College of MedicineClass of 1985
Certifications & Licensure
TN State Medical License 1997 - 2027
TX State Medical License 1991 - 2027
PA State Medical License 1988 - 1994
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification ARIA oncology information system (for Medical Oncology), Varian Medical Systems, 2012, 2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification ARIA Oncology Information System (for Medical Oncology), Varian Medical Systems, 2012, 2014, 2016-2017
- Fellow (FASCO) American Society of Clinical Oncologists, 2010
Clinical Trials
- Thalidomide in Combination With Capecitabine in Patients With Metastatic Breast Cancer Start of enrollment: 2001 Apr 01
- Oral Topotecan Versus Docetaxel in Second-Line Treatment of Non-Small Cell Lung Cancer Start of enrollment: 2000 Nov 01
- Topotecan in Combination With Docetaxel in Refractory and/or Advanced Solid Tumors Start of enrollment: 2002 Feb 01
Publications & Presentations
PubMed
- 24 citationsDurvalumab plus chemotherapy in advanced biliary tract cancer: 3-year overall survival update from the phase III TOPAZ-1 study.Do-Youn Oh, Aiwu Ruth He, Shukui Qin, Li-Tzong Chen, Takuji Okusaka
Journal of Hepatology. 2025-11-01 - 3 citationsctDNA Analysis in ERBB2-Amplified Colorectal Cancer: Biomarker Analysis of the MyPathway Trial.Funda Meric-Bernstam, Kanwal Pratap Singh Raghav, Christopher J Sweeney, Charles Swanton, David R Spigel
Clinical Cancer Research. 2025-07-15 - 10 citationsZanidatamab plus chemotherapy as first-line treatment for patients with HER2-positive advanced gastro-oesophageal adenocarcinoma: primary results of a multicentre, sin...Elena Elimova, Jaffer Ajani, Howard Burris, Crystal S Denlinger, Syma Iqbal
The Lancet. Oncology. 2025-07-01
Lectures
- Maintenance of health-related quality of life in elderly patients treated with ribociclib + letrozole in MONALEESA-2.2018 ASCO Annual Meeting - Chicago, Illinois - 06/2/2018
- Most Patients Should Be Tested2018 ASCO Annual Meeting - Chicago, Illinois - 06/1/2018
- 7th Community Oncology ConferenceGlobal Academy for Medical Education (Elsevier), Las Vegas, Nevada - 3/30/2012
Press Mentions
New Drugs Make Headway Against Lung, Prostate, Colon CancersMay 29th, 2020- Hydroxychloroquine Combination Risky for Cancer Patients with COVID-19May 29th, 2020
Patients with Certain Cancers Are Nearly Three Times as Likely to Die of Covid-19, Study SaysApril 28th, 2020
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
